Philips Unveils Azurion Neuro Biplane System for Enhanced Neurovascular Care

Philips, a global leader in health technology, has unveiled significant advancements to its Image Guided Therapy System – Azurion – with the introduction of the new Azurion neuro biplane system. Engineered to streamline neurovascular procedures and empower care teams to make swift, informed decisions, treat a larger number of patients, and attain superior outcomes, the latest interventional system boasts upgraded 2D and 3D imaging capabilities along with enhanced flexibility in X-ray detector positioning. Amidst the healthcare sector’s pursuit of delivering top-notch patient care, at #ECR2024, Philips is collaborating with its clientele to enhance productivity and facilitate greater access to sustainable healthcare solutions. Minimally invasive procedures facilitated by interventional systems like Azurion play a pivotal role in the diagnosis and treatment continuum for conditions like stroke, where time is of the essence in preserving patients’ quality of life. These systems also aid in meticulously planning and executing intricate neurovascular procedures such as repairing brain aneurysms and addressing congenital defects. By enabling neuro interventionists to efficiently treat more patients, the new Philips Azurion neuro biplane system not only enhances both staff and patient experiences but also contributes to reducing the overall cost of care. Mark Stoffels, Business Leader of Image Guided Therapy Systems at Philips, stated, “Working closely with leading interventionists, we designed the latest Azurion neuro biplane to meet their requirements of superior patient care, optimized angio suite performance, and efficient return on investment. Together, I am confident we can continue to reduce the impact of stroke, helping more patients to recover faster and reducing long-term impact on their health.”

Philips’ Azurion neuro biplane image-guided therapy system is crafted to streamline and optimize procedure workflows where a blend of 2D and 3D imaging is essential for confident diagnosis and precise treatment. When utilized alongside the company’s latest Neuro Suite software and services, it furnishes neuro interventionists with a seamlessly integrated solution that amalgamates Philips’ top-tier ClarityIQ low dose imaging with a suite of neuro-dedicated tools and value-added services, thus offering unprecedented levels of efficiency, flexibility, and control.

Key enhancements in the Azurion neuro biplane system encompass improved C-arm rotation, angulation, and parking facilities facilitating swift transitions between 2D and 3D imaging, comprehensive table-side control negating the need to exit the sterile field, automated beam rotation for obtaining accurately oriented images for every angulation and rotation, and a new head immobilizer to bolster stroke care. Facilitating Expedited Stroke Treatment

Statistics indicate that one in four adults over the age of 25 will experience a stroke at some stage in their lives. Globally, the direct and indirect costs associated with strokes have been estimated at around USD 891 billion annually. The key to mitigating the personal, societal, and financial toll of strokes lies in adhering to the principle that ‘time-is-brain’. The swifter the treatment for strokes, the more favorable the potential outcome.

For ischemic strokes, which constitute 87% of all strokes, the advantages of administering intra-arterial treatment (IAT) within six hours of symptom onset, including mechanical thrombectomy and/or clot-busting agents, are widely acknowledged. As mechanical thrombectomy becomes the standard for addressing large vessel occlusion (LVO) ischemic strokes, the demand for high-utilization angio suites enabling interventionists to operate with speed and efficiency has surged.

In addition to the efficiency-enhancing features of its Azurion platform, Philips is maximizing the uptime of its angio suite solutions by harnessing AI and machine learning to monitor system performance via the new remote connection services offered by the Philips ServiceHub. These services facilitate communication, monitoring, and proactive responses to potential service issues, such as predicting probable component failures at least seven days in advance to enable preemptive action.

With its comprehensive stroke care portfolio, Philips is bridging the gap between caregivers at every crucial juncture in the stroke care continuum, regardless of their locations. The outcome is intelligent stroke solutions designed to bolster connected care.